26608-58-2 Usage
Description
4-(Hydroxymethyl)-1-azabicyclo[2.2.2]octane, also known as 1-Azabicyclo[2.2.2]octan-4-ylmethanol, is an organic compound with a unique bicyclic structure and a hydroxymethyl group. It is a versatile molecule with potential applications in various fields due to its chemical properties and reactivity.
Uses
Used in Pharmaceutical Research:
4-(Hydroxymethyl)-1-azabicyclo[2.2.2]octane is used as a key intermediate in the synthesis of various pharmaceutical compounds, particularly those involving 4-substituted quinuclidines. Its unique structure and reactivity make it a valuable building block for the development of new drugs with potential therapeutic applications.
Used in Chemical Synthesis:
In the field of organic chemistry, 4-(Hydroxymethyl)-1-azabicyclo[2.2.2]octane serves as a versatile starting material for the synthesis of a wide range of organic compounds. Its ability to undergo various chemical reactions, such as nucleophilic substitution, electrophilic addition, and rearrangement reactions, makes it a valuable precursor for the preparation of complex organic molecules.
Used in Material Science:
4-(Hydroxymethyl)-1-azabicyclo[2.2.2]octane can be used as a functional monomer in the development of novel polymeric materials. Its unique bicyclic structure and hydroxymethyl group can be exploited to create polymers with specific properties, such as improved mechanical strength, thermal stability, or biocompatibility, depending on the desired application.
Used in Analytical Chemistry:
4-(Hydroxymethyl)-1-azabicyclo[2.2.2]octane can be employed as a chiral derivatizing agent in the analysis of enantiomers by chromatographic or spectroscopic methods. Its ability to selectively react with specific enantiomers can help in the separation and identification of chiral compounds, which is crucial in various fields, including pharmaceuticals, agrochemicals, and environmental chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 26608-58-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,6,0 and 8 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 26608-58:
(7*2)+(6*6)+(5*6)+(4*0)+(3*8)+(2*5)+(1*8)=122
122 % 10 = 2
So 26608-58-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H15NO/c10-7-8-1-4-9(5-2-8)6-3-8/h10H,1-7H2
26608-58-2Relevant articles and documents
Halogen-Bonded Supramolecular Capsules in the Solid State, in Solution, and in the Gas Phase
Dumele, Oliver,Schreib, Benedikt,Warzok, Ulrike,Trapp, Nils,Schalley, Christoph A.,Diederich, Fran?ois
, p. 1152 - 1157 (2017/01/18)
Supramolecular capsules were assembled by neutral halogen bonding (XB) and studied in the solid state, in solution, and in the gas phase. The geometry of the highly organized capsules is shown by an X-ray crystal structure which features the assembly of t
AZA-BRIDGED-RING COMPOUND
-
Page/Page column 22; 36, (2009/12/05)
[PROBLEMS] Provided is a compound which has an antagonistic action on a muscarinic M3 receptor and is useful as an active ingredient of a prophylactic and/or therapeutic agent for an inflammatory disease such as a chronic obstructive pulmonary disease (COPD), asthma and the like. [MEANS FOR SOLVING PROBLEMS] The present inventors have made studies on a compound having an antagonistic action on the binding of a muscarinic M3 receptor, and they have found that an aza-bridged-ring compound or a salt thereof has an antagonistic action on the binding of a muscarinic M3 receptor, thereby completing the present invention. The aza-bridged-ring compound of the present invention has an antagonistic action on the binding of a muscarinic M3 receptor, and can be used as a prophylactic and/or therapeutic agent for an inflammatory disease such as a chronic obstructive pulmonary disease (COPD), asthma and the like.
Pleuromutilin derivatives as antimicrobials
-
, (2008/06/13)
The present invention relates to pleuromutilin derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medical therapy, particularly antibacterial therapy.
